Selectis Health (GBCS) Gains from Investment Securities (2017 - 2024)
Selectis Health's Gains from Investment Securities history spans 11 years, with the latest figure at $2.1 million for Q2 2024.
- Quarterly results put Gains from Investment Securities at $2.1 million for Q2 2024, changed N/A from a year ago — trailing twelve months through Dec 2024 was $2.1 million (changed N/A YoY), and the annual figure for FY2024 was $2.1 million, changed.
- Gains from Investment Securities for Q2 2024 was $2.1 million at Selectis Health, up from $60000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $2.1 million in Q2 2024 to a low of $60000.0 in Q4 2021.
- The 4-year median for Gains from Investment Securities is $238406.5 (2020), against an average of $551492.7.
- The sharpest move saw Gains from Investment Securities skyrocketed 5754.15% in 2020, then plummeted 77.84% in 2021.
- Year by year, Gains from Investment Securities stood at $270813.0 in 2020, then plummeted by 77.84% to $60000.0 in 2021, then changed by 0.0% to $60000.0 in 2022, then skyrocketed by 3420.24% to $2.1 million in 2024.
- According to Business Quant data, Gains from Investment Securities over the past three periods came in at $2.1 million, $60000.0, and $206000.0 for Q2 2024, Q4 2022, and Q2 2022 respectively.